Inclusion Criteria:  Diagnosis of neovascular age-related macular degeneration Partial response on current anti-VEGF treatment or unability to prolong the treatment interval beyond 6 or 8 weeks  Exclusion Criteria:  1. Any form of previous intraocular inflammation 2. Any form of previous inflammatory reaction after anti-VEGF treatment 3. Functionally monophthalmic patients 4. Any sign of active intraocular inflammation